Company Filing History:
Years Active: 1997-2001
Title: Swati Choksi: Innovator in T Cell Activation Inhibition
Introduction
Swati Choksi is a prominent inventor based in Broomall, PA (US). She has made significant contributions to the field of immunology, particularly in the development of compounds that inhibit CD8 mediated T cell activation. With a total of 2 patents, her work is paving the way for advancements in treatments for various immune-related conditions.
Latest Patents
Swati Choksi's latest patents focus on CD8 antagonists. These compounds are designed to inhibit CD8 mediated T cell activation, targeting specific molecular surfaces of human CD8 at amino acids 38-46, 53-56, and 60-67. The patents disclose methods for inhibiting the activation of human T cells by contacting them with these compounds. Additionally, her work includes methods for treating individuals who are suspected of suffering from or are susceptible to graft versus host disease and organ rejection. The pharmaceutical compositions comprising these compounds are also detailed in her patents.
Career Highlights
Swati Choksi is affiliated with Thomas Jefferson University, where she continues her research and development in immunology. Her innovative approaches to T cell activation have garnered attention in the scientific community, contributing to the understanding of immune responses and potential therapeutic interventions.
Collaborations
Throughout her career, Swati has collaborated with notable colleagues, including Bradford A. Jameson and Robert Korngold. These collaborations have enhanced her research efforts and expanded the impact of her work in the field.
Conclusion
Swati Choksi is a trailblazer in the realm of immunology, with her patents reflecting her commitment to advancing medical science. Her innovative work on CD8 antagonists holds promise for improving treatments for immune-related diseases.